Developing and validating a nomogram to predict myasthenia gravis exacerbation in patients with postoperative thymoma recurrence
Source : https://gs.amegroups.com/article/view/103515/html
Thymoma is a rare and potentially malignant tumor, and complete surgical resection is currently recognized globally as the first choice of treatment ( 1). Nevertheless, 10-30% of patients may have postoperative recurrence ( 2- 4).
Conclusions: We identified the risk factors for MG exacerbation in patients with postoperative recurrence of thymoma and drew a nomogram, which can be used to calculate the probability of MG exacerbation and guide clinicians to choose post-operative treatment.